All In Biotech

Drug Trial Radar · NCT05317416

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION

Last checked: Nov 20, 2026Latest source record: Apr 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 854 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

854

Actual

Start

Mar 25, 2022

Primary completion

Aug 4, 2027

Study completion Oct 31, 2029

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Apr 7, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate whether elranatamab monotherapy can provide clinical benefit compared to lenalidomide monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Part 1 and Part 2 of the study, participants in the study will either receive elranatamab (arm A and C) as an injection under the skin at the study clinic or lenalidomide orally once daily at home (arm B). Participation in the study will be approximately five years

Conditions

  • Multiple Myeloma

Interventions

  • ElranatamabDrug

    BCMA-CD3 bispecific antibody

  • LenalidomideDrug

    Immunomodulatory drug

  • LenalidomideDrug

    Immunomodulatory drug

  • ElranatamabDrug

    BCMA-CD3 bispecific antibody

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression Free SurvivalTime frame: Assessed for up to approximately 5 years

Locations

209 sites in 27 countries. Site status is shown where the registry gives one.

  • Banner Gateway Medical Center

    Gilbert, Arizona

  • Banner Gateway Medical Pavilion

    Gilbert, Arizona

  • Banner MD Anderson Cancer Center

    Gilbert, Arizona

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California

  • UCLA Department of Medicine - Hematology/Oncology

    Los Angeles, California

  • UCLA Hematology/Oncology

    Los Angeles, California

  • Santa Monica UCLA Medical Center & Orthopaedic Hospital

    Santa Monica, California

  • UCLA Hematology/Oncology - Santa Monica

    Santa Monica, California

  • Georgetown University Medical Center

    Washington D.C., District of Columbia

  • Miami Cancer Institute at Baptist Health, Inc.

    Miami, Florida

  • Winship Cancer Institute, Emory University

    Atlanta, Georgia

  • Loyola University Chicago

    Maywood, Illinois

  • Ascentist Doctor Hospital

    Leawood, Kansas

  • University of Michigan

    Ann Arbor, Michigan

  • American Oncology Partners, P.A. Dba MidAmerica Cancer Care

    Kansas City, Missouri

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

  • WMCHealth Advanced Physician Services

    Hawthorne, New York

  • Westchester Medical Center

    Valhalla, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • OhioHealth Arthur G.H. Bing, MD, Cancer Center

    Columbus, Ohio

  • OhioHealth Research Institute

    Columbus, Ohio

  • OhioHealth Riverside Methodist Hospital

    Columbus, Ohio

  • Baylor University Medical Center

    Dallas, Texas

  • Baylor Scott & White Medical Center - Temple

    Temple, Texas

  • Slade Pharmacy

    Richmond, Australia

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • Shoalhaven District Memorial Hospital

    Nowra, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Wollongong Hospital

    Wollongong, New South Wales, Australia

  • Pindara Private Hospital

    Benowa, Queensland, Australia

  • QScan Radiology Clinics

    Clayfield, Queensland, Australia

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia

  • Epworth Healthcare

    East Melbourne, Victoria, Australia

  • Precision Haematology

    East Melbourne, Victoria, Australia

  • St Vincent's Hospital (Melbourne)

    Fitzroy, Victoria, Australia

  • Medizinische Universität Wien

    Vienna, Austria

  • ZNA Middelheim

    Antwerp, Belgium

  • ZNA Cadix

    Antwerp, Belgium

  • UZ Brussel

    Brussels, Belgium

  • Institut Jules Bordet

    Anderlecht, Bruxelles-capitale, Région de, Belgium

Showing 40 of 209 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.